Cargando…

Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain

Objective. To analyze interval cancers among participants in a screening program for colorectal cancer (CRC) during four screening rounds. Methods. The study population consisted of participants of a fecal occult blood test-based screening program from February 2000 to September 2010, with a 30-mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, M., Domènech, X., Vidal, C., Torné, E., Milà, N., Binefa, G., Benito, L., Moreno, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354714/
https://www.ncbi.nlm.nih.gov/pubmed/25802515
http://dx.doi.org/10.1155/2015/672410
_version_ 1782360784727179264
author Garcia, M.
Domènech, X.
Vidal, C.
Torné, E.
Milà, N.
Binefa, G.
Benito, L.
Moreno, V.
author_facet Garcia, M.
Domènech, X.
Vidal, C.
Torné, E.
Milà, N.
Binefa, G.
Benito, L.
Moreno, V.
author_sort Garcia, M.
collection PubMed
description Objective. To analyze interval cancers among participants in a screening program for colorectal cancer (CRC) during four screening rounds. Methods. The study population consisted of participants of a fecal occult blood test-based screening program from February 2000 to September 2010, with a 30-month follow-up (n = 30,480). We used hospital administration data to identify CRC. An interval cancer was defined as an invasive cancer diagnosed within 30 months of a negative screening result and before the next recommended examination. Gender, age, stage, and site distribution of interval cancers were compared with those in the screen-detected group. Results. Within the study period, 97 tumors were screen-detected and 74 tumors were diagnosed after a negative screening. In addition, 17 CRC (18.3%) were found after an inconclusive result and 2 cases were diagnosed within the surveillance interval (2.1%). There was an increase of interval cancers over the four rounds (from 32.4% to 46.0%). When compared with screen-detected cancers, interval cancers were found predominantly in the rectum (OR: 3.66; 95% CI: 1.51–8.88) and at more advanced stages (P = 0.025). Conclusion. There are large numbers of cancer that are not detected through fecal occult blood test-based screening. The low sensitivity should be emphasized to ensure that individuals with symptoms are not falsely reassured.
format Online
Article
Text
id pubmed-4354714
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-43547142015-03-23 Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain Garcia, M. Domènech, X. Vidal, C. Torné, E. Milà, N. Binefa, G. Benito, L. Moreno, V. Gastroenterol Res Pract Research Article Objective. To analyze interval cancers among participants in a screening program for colorectal cancer (CRC) during four screening rounds. Methods. The study population consisted of participants of a fecal occult blood test-based screening program from February 2000 to September 2010, with a 30-month follow-up (n = 30,480). We used hospital administration data to identify CRC. An interval cancer was defined as an invasive cancer diagnosed within 30 months of a negative screening result and before the next recommended examination. Gender, age, stage, and site distribution of interval cancers were compared with those in the screen-detected group. Results. Within the study period, 97 tumors were screen-detected and 74 tumors were diagnosed after a negative screening. In addition, 17 CRC (18.3%) were found after an inconclusive result and 2 cases were diagnosed within the surveillance interval (2.1%). There was an increase of interval cancers over the four rounds (from 32.4% to 46.0%). When compared with screen-detected cancers, interval cancers were found predominantly in the rectum (OR: 3.66; 95% CI: 1.51–8.88) and at more advanced stages (P = 0.025). Conclusion. There are large numbers of cancer that are not detected through fecal occult blood test-based screening. The low sensitivity should be emphasized to ensure that individuals with symptoms are not falsely reassured. Hindawi Publishing Corporation 2015 2015-02-24 /pmc/articles/PMC4354714/ /pubmed/25802515 http://dx.doi.org/10.1155/2015/672410 Text en Copyright © 2015 M. Garcia et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Garcia, M.
Domènech, X.
Vidal, C.
Torné, E.
Milà, N.
Binefa, G.
Benito, L.
Moreno, V.
Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain
title Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain
title_full Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain
title_fullStr Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain
title_full_unstemmed Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain
title_short Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain
title_sort interval cancers in a population-based screening program for colorectal cancer in catalonia, spain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354714/
https://www.ncbi.nlm.nih.gov/pubmed/25802515
http://dx.doi.org/10.1155/2015/672410
work_keys_str_mv AT garciam intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain
AT domenechx intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain
AT vidalc intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain
AT tornee intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain
AT milan intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain
AT binefag intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain
AT benitol intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain
AT morenov intervalcancersinapopulationbasedscreeningprogramforcolorectalcancerincataloniaspain